Concepedia

Mihir Kakara

MK

5

Publications

658

Citations

5

H-Index

2021

Active since

Affiliations

University of Pennsylvania(Current)

La Jolla Institute for Immunology

University of California, San Francisco

Translational Therapeutics (United States)

Parker Institute for Cancer Immunotherapy

Mihir Kakara is an author at University of Pennsylvania specializing in humoral immunity, medicine, and multiple sclerosis.

ORCID

Top concepts

Publications per year

2021–2023

5

Publications

5

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter et al. · Nature Medicine · 2021 · 534 citations · Full text

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

Koji Shinoda, Rui Li, Ayman Rezk et al. · Proceedings of the National Academy of Sciences · 2023 · 50 citations · Full text

Altered cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter et al. · 2021 · 39 citations · Full text

, , +15

<scp>Anti‐CD20</scp> monoclonal antibody therapy in postpartum women with neurological conditions

Annika Anderson, William Rowles, Shane Poole et al. · Annals of Clinical and Translational Neurology · 2023 · 22 citations · Full text

The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis

Joseph R. Berger, Mihir Kakara · Multiple Sclerosis and Related Disorders · 2022 · 13 citations

, , +11

Rows per page

1–5 of 5